Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ischemic Heart Disease

  Free Subscription


Articles published in Catheter Cardiovasc Interv

Retrieve available abstracts of 286 articles:
HTML format
Text format



Single Articles


    May 2018
  1. GUL B, Kozuma K, Haimi I, Zhao W, et al
    Sex disparities in acute myocardial infarction care and outcomes.
    Catheter Cardiovasc Interv. 2018 May 10. doi: 10.1002/ccd.27622.
    PubMed     Text format     Abstract available


  2. AKODAD M, Huet F, Dupuy AM, Lotierzo M, et al
    Letter to the editor concerning "comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary interventi
    Catheter Cardiovasc Interv. 2018 May 4. doi: 10.1002/ccd.27618.
    PubMed     Text format    


    April 2018
  3. MCNEICE A, Nadra IJ, Robinson SD, Fretz E, et al
    The prognostic impact of revascularization strategy in acute myocardial infarction and cardiogenic shock: Insights from the British Columbia Cardiac Registry.
    Catheter Cardiovasc Interv. 2018 Apr 26. doi: 10.1002/ccd.27648.
    PubMed     Text format     Abstract available


    March 2018
  4. NDREPEPA G, Kastrati A
    Rebuttal: Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27617.
    PubMed     Text format    


  5. GOINS AE, Rayson R, Caughey MC, Sola M, et al
    Correlation of infarct size with invasive hemodynamics in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Mar 25. doi: 10.1002/ccd.27625.
    PubMed     Text format     Abstract available


  6. GOLDSWEIG AM, Wang Y, Forrest JK, Cleman MW, et al
    Ventricular septal rupture complicating acute myocardial infarction: Incidence, treatment, and outcomes among medicare beneficiaries 1999-2014.
    Catheter Cardiovasc Interv. 2018 Mar 7. doi: 10.1002/ccd.27576.
    PubMed     Text format     Abstract available


    February 2018
  7. BRILAKIS ES, Eckman P
    The five key "ingredients" for improving outcomes in cardiogenic shock complicating acute myocardial infarction.
    Catheter Cardiovasc Interv. 2018;91:462-463.
    PubMed     Text format     Abstract available


    January 2018
  8. XU N, Tang XF, Yao Y, Zhao X, et al
    Predictive value of neutrophil to lymphocyte ratio in long-term outcomes of left main and/or three-vessel disease in patients with acute myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Jan 13. doi: 10.1002/ccd.27495.
    PubMed     Text format     Abstract available


    December 2017
  9. KIM JH, Kim BK, Kim S, Ahn CM, et al
    Incidence, predicting factors, and clinical outcomes of periprocedural myocardial infarction after percutaneous coronary intervention for chronic total occlusion in the era of new-generation drug-eluting stents.
    Catheter Cardiovasc Interv. 2017 Dec 20. doi: 10.1002/ccd.27420.
    PubMed     Text format     Abstract available


  10. BASIR MB, Schreiber T, Dixon S, Alaswad K, et al
    Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative.
    Catheter Cardiovasc Interv. 2017 Dec 20. doi: 10.1002/ccd.27427.
    PubMed     Text format     Abstract available


  11. GIUSTINO G, Dangas GD
    Ischemia-reperfusion injury and ischemic post-conditioning in acute myocardial infarction: Lost in translation.
    Catheter Cardiovasc Interv. 2017;90:1068-1069.
    PubMed     Text format     Abstract available


    November 2017
  12. GOLDSTEIN JA
    Peri-procedural myocardial infarction: Plaques and patients "at-risk".
    Catheter Cardiovasc Interv. 2017;90:915-916.
    PubMed     Text format     Abstract available


    October 2017
  13. GOYAL A, Tabak SW, Henry TD, Kobashigawa JA, et al
    Omission of heart transplant recipients from the 2017 Appropriate Use Criteria for Coronary Revascularization in patients with stable ischemic heart disease.
    Catheter Cardiovasc Interv. 2017 Oct 31. doi: 10.1002/ccd.27369.
    PubMed     Text format    


  14. EFFRON MB, Wang TY, Fonarow GC, Henry TD, et al
    The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: Insights from the TRANSLATE-ACS study.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27145.
    PubMed     Text format     Abstract available


    September 2017
  15. YUDI MB, Farouque O, Andrianopoulos N, Ajani AE, et al
    Pretreatment with dual antiplatelet therapy in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27325.
    PubMed     Text format     Abstract available


  16. WATANABE H, Morimoto T, Shiomi H, Kawaji T, et al
    Chronic total occlusion in non-infarct-related artery is associated with increased short-and long-term mortality in patients with ST-segment elevation acute myocardial infarction complicated by cardiogenic shock (from the CREDO-Kyoto AMI registry).
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27330.
    PubMed     Text format     Abstract available


  17. GIUSTINO G, Dangas GD
    Integrating invasive hemodynamic parameters into risk stratification of acute myocardial infarction and cardiogenic shock.
    Catheter Cardiovasc Interv. 2017;90:396-397.
    PubMed     Text format     Abstract available


    August 2017
  18. SGUEGLIA GA, D'Errico F, Gioffre G, De Santis A, et al
    Angiographic and clinical performance of polymer-free biolimus-eluting stent in patients with ST-segment elevation acute myocardial infarction in a metropolitan public hospital: The BESAMI MUCHO study.
    Catheter Cardiovasc Interv. 2017 Aug 2. doi: 10.1002/ccd.27206.
    PubMed     Text format     Abstract available


  19. AGRAWAL M, Hakeem A, Ahmed Z, Uretsky BF, et al
    Classification of mechanisms of strut malapposition after angiographically optimized stent implantation: An optical coherence tomography study.
    Catheter Cardiovasc Interv. 2017;90:225-232.
    PubMed     Text format     Abstract available


    July 2017
  20. SINGH K, Rashid M, So DY, Glover CA, et al
    Incidence, predictors, and clinical outcomes of early stent thrombosis in acute myocardial infarction patients treated with primary percutaneous coronary angioplasty (insights from the University of Ottawa Heart Institute STEMI registry).
    Catheter Cardiovasc Interv. 2017 Jul 22. doi: 10.1002/ccd.27215.
    PubMed     Text format     Abstract available


  21. CLAESSEN BE, van den Boogert TPW, Piek JJ
    Recurrent myocardial infarction in a 47-year-old woman with a mechanical mitral valve prosthesis: Atherosclerosis, embolism, or spasm?
    Catheter Cardiovasc Interv. 2017 Jul 12. doi: 10.1002/ccd.27186.
    PubMed     Text format     Abstract available


  22. MIGLIORINI A, Valenti R, Vergara R, Grazia De Gregorio M, et al
    Angiographic and clinical outcome after crush of everolimus-eluting stent for distal unprotected left main disease.
    Catheter Cardiovasc Interv. 2017;90:72-77.
    PubMed     Text format     Abstract available


    June 2017
  23. MCGARVEY M, Ali O, Iqbal MB, Ilsley C, et al
    A feasibility and safety study of intracoronary hemodilution during primary coronary angioplasty in order to reduce reperfusion injury in myocardial infarction.
    Catheter Cardiovasc Interv. 2017 Jun 21. doi: 10.1002/ccd.27136.
    PubMed     Text format     Abstract available


  24. VIEIRA DE MELO RM, Hueb W, Nomura CH, Ribeiro da Silva EE, et al
    Biomarker release after percutaneous coronary intervention in patients without established myocardial infarction as assessed by cardiac magnetic resonance with late gadolinium enhancement.
    Catheter Cardiovasc Interv. 2017 Jun 2. doi: 10.1002/ccd.27125.
    PubMed     Text format     Abstract available


  25. LUONG C, Starovoytov A, Heydari M, Sedlak T, et al
    Clinical presentation of patients with spontaneous coronary artery dissection.
    Catheter Cardiovasc Interv. 2017;89:1149-1154.
    PubMed     Text format     Abstract available


  26. LUNI FK, Riaz H, Khan AR, Riaz T, et al
    Clinical outcomes associated with per-operative discontinuation of aspirin in patients with coronary artery disease: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017;89:1168-1175.
    PubMed     Text format     Abstract available


    May 2017
  27. NDREPEPA G, Colleran R, Braun S, Xhepa E, et al
    Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 May 13. doi: 10.1002/ccd.27105.
    PubMed     Text format     Abstract available


  28. ARORA S, Matsushita K, Qamar A, Stacey RB, et al
    Early versus Late Percutaneous Revascularization in Patients Hospitalized with Non ST-Segment Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Surveillance Study.
    Catheter Cardiovasc Interv. 2017 May 12. doi: 10.1002/ccd.27156.
    PubMed     Text format     Abstract available


  29. VERDOIA M, Barbieri L, Parodi G, Bellandi B, et al
    Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.26967.
    PubMed     Text format     Abstract available


  30. SETO AH, Dehghani P, Shah B, Anwaruddin S, et al
    Late breaking trials of 2016 in coronary artery disease: Commentary covering SCAI, ACC, TCT, EuroPCR, ESC, and AHA.
    Catheter Cardiovasc Interv. 2017;89:1028-1034.
    PubMed     Text format     Abstract available


  31. MORIYAMA N, Tanaka Y, Saito S
    Bailout polytetrafluoroethylene-covered stent implantation for left main bifurcation perforation using the kissing stent technique.
    Catheter Cardiovasc Interv. 2017;89:1022-1027.
    PubMed     Text format     Abstract available


  32. WERNER GS, Glaser P, Coenen A, Moehlis H, et al
    Reduction of radiation exposure during complex interventions for chronic total coronary occlusions: Implementing low dose radiation protocols without affecting procedural success rates.
    Catheter Cardiovasc Interv. 2017;89:1005-1012.
    PubMed     Text format     Abstract available


  33. BOURAS G, Jhamnani S, Ng VG, Haimi I, et al
    Clinical outcomes after PCI treatment of very long lesions with the XIENCE V everolimus eluting stent; Pooled analysis from the SPIRIT and XIENCE V USA prospective multicenter trials.
    Catheter Cardiovasc Interv. 2017;89:984-991.
    PubMed     Text format     Abstract available


  34. ANDRADE PB, Mattos LA, Rinaldi FS, Bienert IC, et al
    Comparison of a vascular closure device versus the radial approach to reduce access site complications in non-ST-segment elevation acute coronary syndrome patients: The angio-seal versus the radial approach in acute coronary syndrome trial.
    Catheter Cardiovasc Interv. 2017;89:976-982.
    PubMed     Text format     Abstract available


    April 2017
  35. SCHREIBER T, Wah Htun W, Blank N, Telila T, et al
    Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry.
    Catheter Cardiovasc Interv. 2017 Apr 18. doi: 10.1002/ccd.26979.
    PubMed     Text format     Abstract available


  36. PATEL A, Nazif T, Stone GW, Ali ZA, et al
    Intraluminal bioresorbable vascular scaffold dismantling with aneurysm formation leading to very late thrombosis.
    Catheter Cardiovasc Interv. 2017;89:876-879.
    PubMed     Text format     Abstract available


  37. AZZALINI L, Dautov R, Ojeda S, Serra A, et al
    Long-term outcomes of rotational atherectomy for the percutaneous treatment of chronic total occlusions.
    Catheter Cardiovasc Interv. 2017;89:820-828.
    PubMed     Text format     Abstract available


  38. MING FAM J, van Der Sijde JN, Karanasos A, Felix C, et al
    Comparison of acute expansion of bioresorbable vascular scaffolds versus metallic drug-eluting stents in different degrees of calcification: An Optical Coherence Tomography Study.
    Catheter Cardiovasc Interv. 2017;89:798-810.
    PubMed     Text format     Abstract available


  39. LEE MS, Lee AC, Shlofmitz RA, Martinsen BJ, et al
    ORBIT II sub-analysis: Impact of impaired renal function following treatment of severely calcified coronary lesions with the Orbital Atherectomy System.
    Catheter Cardiovasc Interv. 2017;89:841-848.
    PubMed     Text format     Abstract available


  40. ORTEGA-PAZ L, Capodanno D, Giacchi G, Gori T, et al
    Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry.
    Catheter Cardiovasc Interv. 2017;89:812-818.
    PubMed     Text format     Abstract available


  41. HUDED CP, Youmans QR, Sweis RN, Ricciardi MJ, et al
    The impact of operator experience during institutional adoption of trans-radial cardiac catheterization.
    Catheter Cardiovasc Interv. 2017;89:860-865.
    PubMed     Text format     Abstract available


  42. SAKAKURA K, Funayama H, Taniguchi Y, Tsurumaki Y, et al
    The incidence of slow flow after rotational atherectomy of calcified coronary arteries: A randomized study of low speed versus high speed.
    Catheter Cardiovasc Interv. 2017;89:832-840.
    PubMed     Text format     Abstract available


  43. HABARA M, Tsuchikane E, Nasu K, Kinoshita Y, et al
    The first clinical experience with a novel directional coronary atherectomy catheter: Preliminary Japanese multicenter experience.
    Catheter Cardiovasc Interv. 2017;89:880-887.
    PubMed     Text format     Abstract available


  44. SETO AH, Kern MJ
    Breaking the code: What is the best post-PCI MI definition?
    Catheter Cardiovasc Interv. 2017;89:857-859.
    PubMed     Text format     Abstract available


  45. SANDOVAL Y, Brilakis ES
    The role of rotational atherectomy in contemporary chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017;89:829-831.
    PubMed     Text format     Abstract available


    March 2017
  46. SOLA M, Venkatesh K, Caughey M, Rayson R, et al
    Ratio of systolic blood pressure to left ventricular end-diastolic pressure at the time of primary percutaneous coronary intervention predicts in-hospital mortality in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.26963.
    PubMed     Text format     Abstract available


  47. KARIMI GALOUGAHI K, Mintz GS, Karmpaliotis D, Ali ZA, et al
    Zero-contrast percutaneous coronary intervention on calcified lesions facilitated by rotational atherectomy.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.26999.
    PubMed     Text format     Abstract available


  48. MAHMOUD AN, Elgendy IY, Mentias A, Saad M, et al
    Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26970.
    PubMed     Text format     Abstract available


  49. ROMAGNOLI E, Gatto L, La Manna A, Burzotta F, et al
    Role of residual acute stent malapposition in percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26974.
    PubMed     Text format     Abstract available


  50. SHARMA D, Kotowycz MA, Sharma V, Choudhury A, et al
    Characteristics and outcomes of patients undergoing percutaneous coronary intervention within 1 year of coronary artery bypass graft surgery.
    Catheter Cardiovasc Interv. 2017 Mar 7. doi: 10.1002/ccd.26853.
    PubMed     Text format     Abstract available


  51. CHE W, Dong H, Jiang X, Peng M, et al
    Subclavian artery stenting for coronary-subclavian steal syndrome.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  52. JIA H, Hu S, Liu H, Zhu Y, et al
    Chronic total occlusion is associated with a higher incidence of malapposition and uncovered stent struts: OCT findings at 6 months following DES implantation.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  53. QI J, Li Y, Li J, Jing Q, et al
    Safety and efficacy of 6-month versus 12-month dual antiplatelet therapy in patients after implantation of multiple biodegradable polymer-coated sirolimus-eluting coronary stents: Insight from the I-LOVE-IT 2 trial.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  54. HU S, Wang C, Zhe C, Zhu Y, et al
    Plaque erosion delays vascular healing after drug eluting stent implantation in patients with acute coronary syndrome: An In Vivo Optical Coherence Tomography Study.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  55. HE C, Ma YL, Wang CS, Song Y, et al
    Effect of coronary dominance on 2-year outcomes after percutaneous coronary intervention in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  56. GAO L, Wang Y, Liu Y, Cao F, et al
    Long-term clinical outcomes of successful revascularization with drug-eluting stents for chronic total occlusions: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  57. QIU M, Li Y, Li J, Xu K, et al
    Impact of six versus 12 months of dual antiplatelet therapy in patients with drug-eluting stent implantation after risk stratification with the residual SYNTAX score: Results from a secondary analysis of the I-LOVE-IT 2 trial.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  58. WANG G, Wang H, Xu B, Yang Y, et al
    Efficacy and safety of a biodegradable polymer Cobalt-Chromium sirolimus-eluting stent (EXCEL2) in treating de novo coronary artery disease: A pooled analysis of the CREDIT II and CREDIT III trials.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  59. XU B, Bettinger N, Guan C, Redfors B, et al
    Impact of completeness of revascularization in complex coronary artery disease as measured with the SYNTAX revascularization index: An SEEDS Substudy.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  60. LATINI RA, Buccheri D, Cortese B
    First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.
    Catheter Cardiovasc Interv. 2017;89:676-678.
    PubMed     Text format     Abstract available


  61. AZZALINI L, Brilakis ES
    Ipsilateral vs. contralateral vs. no collateral (antegrade only) chronic total occlusion percutaneous coronary interventions: What is the right choice for your practice?
    Catheter Cardiovasc Interv. 2017;89:656-657.
    PubMed     Text format    


  62. PALMERINI T
    Myocardial revascularization with percutaneous coronary intervention: To complete or not to complete?
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format    


    February 2017
  63. BABUNASHVILI AM, Pancholy SB, Kartashov DS
    New technique for treatment of postcatheterization radial artery pseudoaneurysm.
    Catheter Cardiovasc Interv. 2017;89:393-398.
    PubMed     Text format     Abstract available


  64. LUZ A, Silveira I, Brochado B, Rodrigues P, et al
    Manual thrombectomy efficiency in relationship to the area at risk in patients with myocardial infarction with TIMI 0-1 coronary flow: Insights from an all comers registry.
    Catheter Cardiovasc Interv. 2017 Feb 13. doi: 10.1002/ccd.26959.
    PubMed     Text format     Abstract available


  65. ZHANG D, Li Y, Yin D, He Y, et al
    Risk stratification of periprocedural myocardial infarction after percutaneous coronary intervention: Analysis based on the SCAI definition.
    Catheter Cardiovasc Interv. 2017 Feb 13. doi: 10.1002/ccd.26939.
    PubMed     Text format     Abstract available


  66. SOUZA CF, Maehara A, Mintz GS, Matsumura M, et al
    Tissue characterization and phenotype classification in patients presenting with acute myocardial infarction: Insights from the iWonder study.
    Catheter Cardiovasc Interv. 2017 Feb 13. doi: 10.1002/ccd.26954.
    PubMed     Text format     Abstract available


  67. DEHARO P, Strange JW, Mozid A
    Primary percutaneous coronary intervention of native chronic total occlusions to treat ST elevation myocardial infarction secondary to acute vein graft occlusion.
    Catheter Cardiovasc Interv. 2017 Feb 10. doi: 10.1002/ccd.26905.
    PubMed     Text format     Abstract available


  68. RAVAT H, Garekar S, Changela V
    Left main coronary angioplasty of a 9-year-old child with bioresorable vascular scaffold.
    Catheter Cardiovasc Interv. 2017 Feb 10. doi: 10.1002/ccd.26896.
    PubMed     Text format     Abstract available


  69. CZARNY MJ, Hwang CW, Naiman DQ, Lemmon CC, et al
    Heparin versus bivalirudin for non-primary percutaneous coronary intervention: A post-Hoc analysis of the CPORT-E trial.
    Catheter Cardiovasc Interv. 2017 Feb 4. doi: 10.1002/ccd.26953.
    PubMed     Text format     Abstract available


  70. OH JH, Song S, Kim C, Kim J, et al
    The influence of side branch stenosis on fractional flow reserve assessment of the main branch in a swine model.
    Catheter Cardiovasc Interv. 2017;89:219-225.
    PubMed     Text format     Abstract available


  71. GARBO R, Oreglia JA, Gasparini GL
    The Balloon-Microcatheter technique for treatment of coronary artery perforations.
    Catheter Cardiovasc Interv. 2017;89:E75-E83.
    PubMed     Text format     Abstract available


  72. SAWAYA FJ, Morice MC, Spaziano M, Mehran R, et al
    Short-versus long-term Dual Antiplatelet therapy after drug-eluting stent implantation in women versus men: A sex-specific patient-level pooled-analysis of six randomized trials.
    Catheter Cardiovasc Interv. 2017;89:178-189.
    PubMed     Text format     Abstract available


  73. KERN MJ, Seto AH
    Does pre-PCI FFR predict post-PCI blood flow increase? do we need IMR too?
    Catheter Cardiovasc Interv. 2017;89:243-244.
    PubMed     Text format    


  74. HENRY TD, Pepine CJ, Lambert CR, Traverse JH, et al
    The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction.
    Catheter Cardiovasc Interv. 2017;89:169-177.
    PubMed     Text format     Abstract available


  75. VISVESWARAN GK, Cohen M, Seliem A, DiVita M, et al
    A single center tertiary care experience utilizing the large volume mega 50cc intra-aortic balloon counterpulsation in contemporary clinical practice.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26908.
    PubMed     Text format     Abstract available


    January 2017
  76. CHATTERJEE S, Kundu A, Mukherjee D, Sardar P, et al
    Risk of contrast-induced acute kidney injury in ST-elevation myocardial infarction patients undergoing multi-vessel intervention-meta-analysis of randomized trials and risk prediction modeling study using observational data.
    Catheter Cardiovasc Interv. 2017 Jan 23. doi: 10.1002/ccd.26928.
    PubMed     Text format     Abstract available


  77. GUAN C, Xu B, Qiao S, Qin L, et al
    Comparison of two biodegradable-polymer-based sirolimus-eluting stents with varying elution and absorption kinetics in patients with acute myocardial infarction: A subgroup analysis of the PANDA III trial.
    Catheter Cardiovasc Interv. 2017 Jan 21. doi: 10.1002/ccd.26918.
    PubMed     Text format     Abstract available


  78. TENEKECIOGLU E, Albuquerque FN, Sotomi Y, Zeng Y, et al
    Intracoronary optical coherence tomography: Clinical and research applications and intravascular imaging software overview.
    Catheter Cardiovasc Interv. 2017 Jan 21. doi: 10.1002/ccd.26920.
    PubMed     Text format     Abstract available


  79. BROWN ED, Blankenship JC
    A mechanism for stroke complicating thrombus aspiration.
    Catheter Cardiovasc Interv. 2017;89:93-96.
    PubMed     Text format     Abstract available


  80. XHEPA E, Tada T, Kufner S, Ndrepepa G, et al
    Long-term prognostic value of risk scores after drug-eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR-LEFT-MAIN and ISAR-LEFT-MAIN 2 randomized clinical trials.
    Catheter Cardiovasc Interv. 2017;89:1-10.
    PubMed     Text format     Abstract available


  81. KAWAMOTO H, Takagi K, Chieffo A, Ruparelia N, et al
    Long-term outcomes following mini-crush versus culotte stenting for the treatment of unprotected left main disease: Insights from the milan and New-Tokyo (MITO) registry.
    Catheter Cardiovasc Interv. 2017;89:13-24.
    PubMed     Text format     Abstract available


  82. NAGANUMA T, Colombo A, Lesiak M, Capodanno D, et al
    Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry.
    Catheter Cardiovasc Interv. 2017;89:47-56.
    PubMed     Text format     Abstract available


  83. BELARDI JA, Albertal M
    Double-stenting in distal left main lesions: Let's crush.
    Catheter Cardiovasc Interv. 2017;89:24-25.
    PubMed     Text format     Abstract available


  84. NUNEZ LOPEZ VF, Cohen MG
    The elusive prediction of stent thrombosis.
    Catheter Cardiovasc Interv. 2017;89:35-36.
    PubMed     Text format     Abstract available


  85. CHATTERJEE A, Hillegass WB
    Unprotected Left Main Disease and Percutaneous Intervention: A Prototype for Precision Medicine.
    Catheter Cardiovasc Interv. 2017;89:11-12.
    PubMed     Text format     Abstract available


  86. URIBE CE, Zuniga M, Madrid C
    Mechanical thrombectomy using the Solitaire stent in a left main coronary artery: A novel approach to coronary thrombus retrieval.
    Catheter Cardiovasc Interv. 2017;89:71-77.
    PubMed     Text format     Abstract available


    December 2016
  87. NOMAN A, Balasubramaniam K, Alhous MH, Lee K, et al
    Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
    Catheter Cardiovasc Interv. 2016 Dec 28. doi: 10.1002/ccd.26882.
    PubMed     Text format     Abstract available


  88. NGUYEN-TRONG PJ, Martinez Parachini JR, Resendes E, Karatasakis A, et al
    Procedural outcomes with use of the flash ostial system in aorto-coronary ostial lesions.
    Catheter Cardiovasc Interv. 2016;88:1067-1074.
    PubMed     Text format     Abstract available


  89. AL BADRI A, Henry TD
    Post PCI Angina: Painful in Many Ways!
    Catheter Cardiovasc Interv. 2016;88:1025-1026.
    PubMed     Text format     Abstract available


    November 2016
  90. SHARKAWI MA, Filippaios A, Dani SS, Shah SP, et al
    Identifying patients for safe early hospital discharge following st elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2016 Nov 29. doi: 10.1002/ccd.26873.
    PubMed     Text format     Abstract available


  91. DANEK BA, Brilakis ES
    Serenity, courage, and wisdom: The keys to successful coronary calcification treatment.
    Catheter Cardiovasc Interv. 2016;88:897-898.
    PubMed     Text format    


  92. KORNOWSKI R
    Bifurcation stenting with bioresorbable scaffolds: Quo vadis?
    Catheter Cardiovasc Interv. 2016;88:863-864.
    PubMed     Text format    


  93. SAFIAN RD
    Provisional rotablator for calcified lesions: The Russian roulette of PCI.
    Catheter Cardiovasc Interv. 2016;88:889-890.
    PubMed     Text format    


  94. LEESAR MA
    Bioresorbable vascular scaffolds in coronary bifurcation lesions: The next frontiers?
    Catheter Cardiovasc Interv. 2016;88:870-871.
    PubMed     Text format    


  95. RIZIK DG, Shah MG, Burke RF
    First US experience following FDA approval of the ABBOTT vascular bioresorbable vascular scaffold for the treatment of coronary artery disease.
    Catheter Cardiovasc Interv. 2016;88:899-901.
    PubMed     Text format     Abstract available


  96. JAGUSZEWSKI M, Dorig M, Frangieh AH, Ghadri JR, et al
    Safety and efficacy profile of bioresorbable-polylactide-polymer-biolimus-A9-eluting stents versus durable-polymer-everolimus- and zotarolimus-eluting stents in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2016;88:E173-E182.
    PubMed     Text format     Abstract available


  97. TANAKA A, Jabbour RJ, Kawamoto H, Mangieri A, et al
    Preliminary Report of Clinical Outcomes After Single Crossover Bioresorbable Scaffold Implantation Without Routine Side Branch Strut Dilation.
    Catheter Cardiovasc Interv. 2016;88:865-870.
    PubMed     Text format     Abstract available


  98. TANAKA A, Latib A, Kawamoto H, Jabbour RJ, et al
    Clinical outcomes following bifurcation double-stenting with bioresorbable scaffolds.
    Catheter Cardiovasc Interv. 2016;88:854-862.
    PubMed     Text format     Abstract available


  99. BENNETT J, Adriaenssens T, Desmet W, Dubois C, et al
    Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and d
    Catheter Cardiovasc Interv. 2016;88:843-853.
    PubMed     Text format     Abstract available


  100. TROBS M, Achenbach S, Rother J, Klinghammer L, et al
    Bioresorbable vascular scaffold thrombosis in a consecutive cohort of 550 patients.
    Catheter Cardiovasc Interv. 2016;88:872-880.
    PubMed     Text format     Abstract available


  101. IANNACCONE M, Barbero U, D'ascenzo F, Latib A, et al
    Rotational atherectomy in very long lesions: Results for the ROTATE registry.
    Catheter Cardiovasc Interv. 2016;88:E164-E172.
    PubMed     Text format     Abstract available


  102. KAWAMOTO H, Latib A, Ruparelia N, Boccuzzi GG, et al
    Planned versus provisional rotational atherectomy for severe calcified coronary lesions: Insights From the ROTATE multi-center registry.
    Catheter Cardiovasc Interv. 2016;88:881-889.
    PubMed     Text format     Abstract available


  103. LA MANNA A, Chisari A, Giacchi G, Capodanno D, et al
    Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug-eluting stents for percutaneous treatment of chronic total coronary occlusions: Technical and procedural outcomes from the GHOST-CTO registry.
    Catheter Cardiovasc Interv. 2016;88:E155-E163.
    PubMed     Text format     Abstract available


  104. KOIFMAN E, Gaglia MA Jr, Escarcega RO, Bernardo NL, et al
    Comparison of transradial and transfemoral access in patients undergoing percutaneous coronary intervention for complex coronary lesions.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26669.
    PubMed     Text format     Abstract available


  105. WIMMER NJ, Dufour AB, Cho K, Gagnon DR, et al
    Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26831.
    PubMed     Text format     Abstract available


  106. CHENG R, Vanichsarn C, Patel JK, Currier J, et al
    Long-term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus-eluting stents for the treatment of cardiac allograft vasculopathy.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26830.
    PubMed     Text format     Abstract available


  107. SHAH R, Matin K, Rogers KC, Rao SV, et al
    Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26859.
    PubMed     Text format     Abstract available


  108. SARRAF M, Hillegass W
    Routine invasive evaluation in non ST elevation myocardial infarction (NSTEMI-ACS): Optimizing best.
    Catheter Cardiovasc Interv. 2016;88:775-776.
    PubMed     Text format    


  109. BLANKENSHIP JC
    Thrombus aspiration: Suck it up and keep looking for a niche.
    Catheter Cardiovasc Interv. 2016;88:725-726.
    PubMed     Text format    


  110. SETO AH, Kern MJ
    Does the AToMIC trial explode concerns of contrast coagulopathy?
    Catheter Cardiovasc Interv. 2016;88:738-739.
    PubMed     Text format    


  111. FARHAN S, Mehran R
    STEMI with multivessel disease: An ongoing battle for the optimal treatment strategy.
    Catheter Cardiovasc Interv. 2016;88:707-708.
    PubMed     Text format    


  112. BUTMAN SM
    The newly occluded ectatic vessel: Not an ecstatic time.
    Catheter Cardiovasc Interv. 2016;88:753-754.
    PubMed     Text format    


  113. SHARMA R, Henry TD
    Come one, come all...the sooner the better!
    Catheter Cardiovasc Interv. 2016;88:689-690.
    PubMed     Text format    


  114. RIZIK DG, Hermiller JB, Kereiakes DJ
    Bioresorbable vascular scaffolds for the treatment of coronary artery disease: Clinical outcomes from randomized controlled trials.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available


  115. CHAMIE D, Garcia-Garcia H, Costa RA, Onuma Y, et al
    Role of invasive imaging in acute and long-term assessment of bioresorbable scaffold technology.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available


  116. PERKINS LE, Kossuth MB, Fox JC, Rapoza RJ, et al
    Paving the way to a bioresorbable technology: Development of the absorb BRS program.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available


  117. TAMBURINO C, Capranzano P, Francaviglia B, Ina Tamburino C, et al
    Update on clinical evidence (Part II): A summary of the main post market studies.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available


  118. TANAKA A, Jabbour RJ, Latib A, Colombo A, et al
    Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available


  119. ABIZAID A, Ribamar Costa J Jr
    The unmet needs: How future technologies will address current limitations of bioresorbable scaffold technology.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available


  120. BADINGS EA, Remkes WS, The SH, Dambrink JE, et al
    Early or late intervention in patients with transient ST-segment elevation acute coronary syndrome: Subgroup analysis of the ELISA-3 trial.
    Catheter Cardiovasc Interv. 2016;88:755-764.
    PubMed     Text format     Abstract available


  121. ELGENDY IY, Kumbhani DJ, Mahmoud AN, Wen X, et al
    Routine invasive versus selective invasive strategies for Non-ST-elevation acute coronary syndromes: An Updated meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2016;88:765-774.
    PubMed     Text format     Abstract available


  122. THEODOROPOULOS K, Mennuni MG, Dangas GD, Meelu OA, et al
    Resistant in-stent restenosis in the drug eluting stent era.
    Catheter Cardiovasc Interv. 2016;88:777-785.
    PubMed     Text format     Abstract available


  123. JINNOUCHI H, Kuramitsu S, Shinozaki T, Hiromasa T, et al
    Two-year clinical outcomes of the NOBORI biolimus-eluting stents versus XIENCE/PROMUS everolimus-eluting stents in small vessel disease.
    Catheter Cardiovasc Interv. 2016;88:E132-E138.
    PubMed     Text format     Abstract available


  124. KHOT UN, Johnson-Wood ML, VanLeeuwen R, Ramsey C, et al
    A hospital-wide system to ensure rapid treatment time across the entire spectrum of emergency percutaneous intervention.
    Catheter Cardiovasc Interv. 2016;88:678-689.
    PubMed     Text format     Abstract available


    October 2016
  125. IELASI A, Varricchio A, Campo G, Leoncini M, et al
    A prospective evaluation of a standardized strategy for the use of a polymeric everolimus-eluting bioresorbable scaffold in ST-segment elevation myocardial infarction: Rationale and design of the BVS STEMI STRATEGY-IT study.
    Catheter Cardiovasc Interv. 2016 Oct 24. doi: 10.1002/ccd.26801.
    PubMed     Text format     Abstract available


  126. EFTYCHIOU C, Barmby DS, Wilson SJ, Ubaid S, et al
    Cardiovascular Outcomes Following Rotational Atherectomy: A UK Multicentre Experience.
    Catheter Cardiovasc Interv. 2016;88:546-553.
    PubMed     Text format     Abstract available


  127. YETGIN T, van Kranenburg M, Ten Cate T, Duncker DJ, et al
    Ischemic Postconditioning After Routine Thrombus Aspiration During Primary Percutaneous Coronary Intervention: Rationale and Design of the POstconditioning Rotterdam Trial.
    Catheter Cardiovasc Interv. 2016;88:508-514.
    PubMed     Text format     Abstract available


  128. TEBALDI M, Biscaglia S, Fineschi M, Manari A, et al
    Fractional Flow Reserve Evaluation and Chronic Kidney Disease: Analysis From a Multicenter Italian Registry (the FREAK Study).
    Catheter Cardiovasc Interv. 2016;88:555-562.
    PubMed     Text format     Abstract available


  129. BASAVARAJAIAH S, Naganuma T, Latib A, Sticchi A, et al
    Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study.
    Catheter Cardiovasc Interv. 2016;88:522-528.
    PubMed     Text format     Abstract available


  130. TIAN W, Mahmoudi M, Lhermusier T, Kiramijyan S, et al
    The influence of advancing age on implantation of drug-eluting stents.
    Catheter Cardiovasc Interv. 2016;88:516-521.
    PubMed     Text format     Abstract available


  131. SINGH S, Singh N, Gulati GS, Ramakrishnan S, et al
    Dual-Source Computed Tomography for Chronic Total Occlusion of Coronary Arteries.
    Catheter Cardiovasc Interv. 2016;88:E117-E125.
    PubMed     Text format     Abstract available


  132. CHADHA DS, Sumana B, Karthikeyan G, Jayaprasad V, et al
    Prevalence of aspirin resistance in Asian-Indian patients with stable coronary artery disease.
    Catheter Cardiovasc Interv. 2016;88:E126-E131.
    PubMed     Text format     Abstract available


  133. BELARDI JA, Albertal M
    Ischemic Postconditioning: Not Giving Up Yet.
    Catheter Cardiovasc Interv. 2016;88:514-515.
    PubMed     Text format     Abstract available


  134. SAFIAN RD
    The Third Rail of Interventional Cardiology: Revascularization of Non-Infarct-Related Arteries During Primary PCI.
    Catheter Cardiovasc Interv. 2016;88:506-507.
    PubMed     Text format    


  135. HIRA RS, Dean LS
    Fracking the Code to Complete Revascularization.
    Catheter Cardiovasc Interv. 2016;88:553-554.
    PubMed     Text format     Abstract available


  136. KAPUR NK, Esposito M
    Small Acute Mechanical Circulatory Support Pumps for Small People.
    Catheter Cardiovasc Interv. 2016;88:590-591.
    PubMed     Text format    


  137. HEUSER RR
    ACS Treatment Continues to Improve: But Price Matters.
    Catheter Cardiovasc Interv. 2016;88:544-545.
    PubMed     Text format     Abstract available


    September 2016
  138. WANG H, Li Y, Cong H, Ding S, et al
    Efficiency and safety of bivalirudin in patients undergoing emergency percutaneous coronary intervention via radial access: A subgroup analysis from the bivalirudin in acute myocardial infarction versus heparin and GPI plus heparin trial.
    Catheter Cardiovasc Interv. 2016 Sep 28. doi: 10.1002/ccd.26804.
    PubMed     Text format     Abstract available


  139. VERMA S, Burkhoff D, O'Neill WW
    Avoiding hemodynamic collapse during high-risk percutaneous coronary intervention: Advanced hemodynamics of impella support.
    Catheter Cardiovasc Interv. 2016 Sep 23. doi: 10.1002/ccd.26795.
    PubMed     Text format     Abstract available


  140. HARPER AR, Dawkins S, Newton JD
    Late subannular aortic root rupture following transcatheter aortic valve implantation presenting as ST elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26724.
    PubMed     Text format     Abstract available


  141. CHANDRASEKHAR J, Bansilal S, Baber U, Sartori S, et al
    Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26716.
    PubMed     Text format     Abstract available


  142. SUKUL D, Seth M, Dixon SR, Zainea M, et al
    Clinical outcomes of percutaneous coronary intervention in patients turned down for surgical revascularization.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26781.
    PubMed     Text format     Abstract available


  143. DILETTI R, Tchetche D, Barbato E, Latib A, et al
    Bioresorbable scaffolds for treatment of coronary bifurcation lesions: Critical appraisal and future perspectives.
    Catheter Cardiovasc Interv. 2016;88:397-406.
    PubMed     Text format     Abstract available


  144. NAIDU SS, Aronow HD, Box LC, Duffy PL, et al
    SCAI expert consensus statement: 2016 best practices in the cardiac catheterization laboratory: (Endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologia intervencionista; Affirmation of value by the Canadian Associ
    Catheter Cardiovasc Interv. 2016;88:407-23.
    PubMed     Text format    


  145. GENEREUX P, Bettinger N, Redfors B, Lee AC, et al
    Two-year outcomes after treatment of severely calcified coronary lesions with the orbital atherectomy system and the impact of stent types: Insight from the ORBIT II trial.
    Catheter Cardiovasc Interv. 2016;88:369-77.
    PubMed     Text format     Abstract available


  146. LESCHKE M, Waliszewski M, Pons M, Champin S, et al
    Thin strut bare metal stents in patients with atrial fibrillation: Is there still a need for BMS?
    Catheter Cardiovasc Interv. 2016;88:358-66.
    PubMed     Text format     Abstract available


  147. VELAGAPUDI P, Abbott JD
    Defining small vessels and bioresorbable vascular scaffold outcomes.
    Catheter Cardiovasc Interv. 2016;88:388-9.
    PubMed     Text format     Abstract available


  148. SOTOMI Y, Serruys PW
    Promising, but still a matter of debate.
    Catheter Cardiovasc Interv. 2016;88:378-9.
    PubMed     Text format     Abstract available


  149. GOLDSTEIN JA
    Stenting precision: "Image small, miss small".
    Catheter Cardiovasc Interv. 2016;88:348-9.
    PubMed     Text format     Abstract available


    August 2016
  150. KORABATHINA R, Levine JC, Coppola JT
    Innovative use of a guideliner catheter to assist in snare retrieval of an entrapped kinked guide catheter during transradial coronary intervention.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26774.
    PubMed     Text format     Abstract available


  151. KANG SJ, Yang DH, Koo HJ, Yun SC, et al
    Intravascular ultrasound-derived morphological predictors of myocardial ischemia assessed by stress myocardial perfusion computed tomography.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26710.
    PubMed     Text format     Abstract available


  152. PYXARAS SA, Toth GG, Di Gioia G, Ughi GJ, et al
    Anatomical and functional assessment of Tryton bifurcation stent before and after final kissing balloon dilatation: Evaluations by three-dimensional coronary angiography, optical coherence tomography imaging and fractional flow reserve.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26777.
    PubMed     Text format     Abstract available


  153. ROGGEN M, Dubois C, Gewillig M
    Coronary artery stenting in a patient with progeria.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26730.
    PubMed     Text format     Abstract available


  154. MOTTILLO S, Filion KB, Joseph L, Eisenberg MJ, et al
    Defining optimal activated clotting time for percutaneous coronary intervention: A systematic review and Bayesian meta-regression.
    Catheter Cardiovasc Interv. 2016 Aug 22. doi: 10.1002/ccd.26652.
    PubMed     Text format     Abstract available


  155. KAWAMOTO H, Ruparelia N, Latib A, Miyazaki T, et al
    Expansion in calcific lesions and overall clinical outcomes following bioresorbable scaffold implantation optimized with intravascular ultrasound.
    Catheter Cardiovasc Interv. 2016 Aug 22. doi: 10.1002/ccd.26725.
    PubMed     Text format     Abstract available


  156. YANG X, Tamez H, Lai C, Ho K, et al
    Type 4a myocardial infarction: Incidence, risk factors, and long-term outcomes.
    Catheter Cardiovasc Interv. 2016 Aug 18. doi: 10.1002/ccd.26688.
    PubMed     Text format     Abstract available


  157. DANEK BA, Karatasakis A, Alame AJ, Nguyen-Trong PJ, et al
    Saphenous vein graft near-infrared spectroscopy imaging insights from the lipid core plaque association with clinical events near-infrared spectroscopy (ORACLE-NIRS) registry.
    Catheter Cardiovasc Interv. 2016 Aug 18. doi: 10.1002/ccd.26696.
    PubMed     Text format     Abstract available


  158. FERKO N, Ferrante G, Hasegawa JT, Schikorr T, et al
    Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2016 Aug 16. doi: 10.1002/ccd.26700.
    PubMed     Text format     Abstract available


  159. RHEUDE TA, Xhepa E, Byrne RA
    Markedly different tissue types on optical coherence tomography imaging in a patient with multiple lesion drug-eluting stent in-stent restenosis.
    Catheter Cardiovasc Interv. 2016 Aug 16. doi: 10.1002/ccd.26694.
    PubMed     Text format     Abstract available


  160. AGGARWAL V, Mishkel G, Goswami N
    Percutaneous exclusion of a rapidly enlarging left main coronary artery aneurysm using coils and an Amplatzer septal occluder.
    Catheter Cardiovasc Interv. 2016;88:209-14.
    PubMed     Text format     Abstract available


    July 2016
  161. JOHNSON PM, Madamanchi C, Sharalaya ZM, Iqbal Z, et al
    Angiographic severity does not correlate with fractional flow reserve in heavily calcified coronary arteries.
    Catheter Cardiovasc Interv. 2016 Jul 28. doi: 10.1002/ccd.26635.
    PubMed     Text format     Abstract available


  162. ROSSINI R, Angiolillo DJ, Musumeci G, Capodanno D, et al
    Antiplatelet therapy and outcome in patients undergoing surgery following coronary stenting: Results of the surgery after stenting registry.
    Catheter Cardiovasc Interv. 2016 Jul 12. doi: 10.1002/ccd.26629.
    PubMed     Text format     Abstract available


  163. MANOLY I, Hasan R, Brazier A, Farooq V, et al
    Feasibility of hybrid off pump artery bypass grafting and transaortic transcatheter aortic valve implantation: A case series.
    Catheter Cardiovasc Interv. 2016 Jul 12. doi: 10.1002/ccd.26610.
    PubMed     Text format     Abstract available


  164. COLLERAN R, Kufner S, Harada Y, Giacoppo D, et al
    Five-year follow-up of polymer-free sirolimus- and probucol-eluting stents versus new generation zotarolimus-eluting stents in patients presenting with st-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2016 Jul 5. doi: 10.1002/ccd.26597.
    PubMed     Text format     Abstract available


  165. MASHAYEKHI K, Behnes M, Valuckiene Z, Bryniarski L, et al
    Comparison of the ipsi-lateral versus contra-lateral retrograde approach of percutaneous coronary interventions in chronic total occlusions.
    Catheter Cardiovasc Interv. 2016 Jul 5. doi: 10.1002/ccd.26611.
    PubMed     Text format     Abstract available


  166. COLLET C, Serruys PW
    Coronary bifurcations in clinical practice: Tell me what we can do better.
    Catheter Cardiovasc Interv. 2016;88:71-2.
    PubMed     Text format     Abstract available


  167. BUTMAN SM
    In early returns scoring scores big.
    Catheter Cardiovasc Interv. 2016;88:60-1.
    PubMed     Text format     Abstract available


  168. KRISHNAN SK, Henry TD
    The bare naked truth... "excuse me but your metal is showing!".
    Catheter Cardiovasc Interv. 2016;88:36-7.
    PubMed     Text format     Abstract available


  169. DANEK BA, Brilakis ES
    How to prevent and treat complications of the retrograde approach to chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016;88:15-7.
    PubMed     Text format     Abstract available


    June 2016
  170. CHATTERJEE S, Yeh RW, Sardar P, Ul Hassan Virk H, et al
    Is multivessel intervention in ST-elevation myocardial infarction associated with early harm? Insights from observational data.
    Catheter Cardiovasc Interv. 2016 Jun 24. doi: 10.1002/ccd.26643.
    PubMed     Text format     Abstract available


  171. COCKBURN J, Dooley M, Parker J, Hill A, et al
    Transcatheter aortic valve-in-valve treatment of degenerative stentless supra-annular Freedom Solo valves: A single centre experience.
    Catheter Cardiovasc Interv. 2016 Jun 17. doi: 10.1002/ccd.26623.
    PubMed     Text format     Abstract available


  172. ARMSTRONG EJ, Graham L, Waldo SW, Valle JA, et al
    Patient and lesion-specific characteristics predict risk of major adverse cardiovascular events among patients with previous percutaneous coronary intervention undergoing noncardiac surgery.
    Catheter Cardiovasc Interv. 2016 Jun 17. doi: 10.1002/ccd.26624.
    PubMed     Text format     Abstract available


  173. ELLWEIN L, Marks DS, Migrino RQ, Foley WD, et al
    Image-based quantification of 3D morphology for bifurcations in the left coronary artery: Application to stent design.
    Catheter Cardiovasc Interv. 2016;87:1244-55.
    PubMed     Text format     Abstract available


  174. SETO AH, Jordan Safirstein, Anwaruddin S, Dehghani P, et al
    Late breaking trials of 2015 in coronary artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA.
    Catheter Cardiovasc Interv. 2016;87:1224-30.
    PubMed     Text format     Abstract available


  175. SARDAR MR, Dawn Abbott J
    Myocardial salvage and mortality in STEMI: A race against ischemic time.
    Catheter Cardiovasc Interv. 2016;87:1201-2.
    PubMed     Text format     Abstract available


    May 2016
  176. FAZA NN, Mentias A, Parashar A, Chaudhury P, et al
    Bleeding Complications of Triple Antithrombotic Therapy after Percutaneous Coronary Interventions.
    Catheter Cardiovasc Interv. 2016 May 24. doi: 10.1002/ccd.26574.
    PubMed     Text format     Abstract available


  177. JOSHI FR, Biasco L, Pedersen F, Holmvang L, et al
    Invasive angiography and revascularization in patients with stable angina following prior coronary artery bypass grafting: Results from the East Denmark heart registry.
    Catheter Cardiovasc Interv. 2016 May 24. doi: 10.1002/ccd.26598.
    PubMed     Text format     Abstract available


  178. MURAI T, Kanaji Y, Yonetsu T, Lee T, et al
    Preprocedural fractional flow reserve and microvascular resistance predict increased hyperaemic coronary flow after elective percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016 May 24. doi: 10.1002/ccd.26596.
    PubMed     Text format     Abstract available


  179. MAHMUD E, Dominguez A, Bahadorani J
    First-in-human robotic percutaneous coronary intervention for unprotected left main stenosis.
    Catheter Cardiovasc Interv. 2016 May 18. doi: 10.1002/ccd.26550.
    PubMed     Text format     Abstract available


  180. KARATASAKIS A, Tarar MN, Karmpaliotis D, Alaswad K, et al
    Guidewire and microcatheter utilization patterns during antegrade wire escalation in chronic total occlusion percutaneous coronary intervention: Insights from a contemporary multicenter registry.
    Catheter Cardiovasc Interv. 2016 May 17. doi: 10.1002/ccd.26568.
    PubMed     Text format     Abstract available


  181. ASGAR A, Chandrasekhar J, Mikhail G, Webb J, et al
    Sex-Based Differences In Outcomes With Bivalirudin Or Unfractionated Heparin For Transcatheter Aortic Valve Replacement: Results From The BRAVO 3 Randomized Trial.
    Catheter Cardiovasc Interv. 2016 May 6. doi: 10.1002/ccd.26607.
    PubMed     Text format     Abstract available


  182. HARI P, Kirtane AJ, Bangalore S
    Retrograde approach to an ostial left anterior descending chronic total occlusion through a left internal mammary artery graft.
    Catheter Cardiovasc Interv. 2016;87:E224-8.
    PubMed     Text format     Abstract available


  183. BLANKENSHIP JC
    Passion: A day in the life of an interventionalist.
    Catheter Cardiovasc Interv. 2016;87:999-1000.
    PubMed     Text format    


  184. LADWINIEC A, Cunnington MS, Rossington J, Thackray S, et al
    Microvascular dysfunction in the immediate aftermath of chronic total coronary occlusion recanalization.
    Catheter Cardiovasc Interv. 2016;87:1071-9.
    PubMed     Text format     Abstract available


  185. GOEL SS, Dilip Gajulapalli R, Athappan G, Philip F, et al
    Management of drug eluting stent in-stent restenosis: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2016;87:1080-91.
    PubMed     Text format     Abstract available


  186. WOLFF R, Fefer P, Knudtson ML, Cheema AN, et al
    Gender differences in the prevalence and treatment of coronary chronic total occlusions.
    Catheter Cardiovasc Interv. 2016;87:1063-70.
    PubMed     Text format     Abstract available


  187. LEVINE GN, Bates ER, Blankenship JC, Bailey SR, et al
    2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial Infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline f
    Catheter Cardiovasc Interv. 2016;87:1001-19.
    PubMed     Text format    


  188. CARLINO M, Ruparelia N, Thomas G, Brooks M, et al
    Modified contrast microinjection technique to facilitate chronic total occlusion recanalization.
    Catheter Cardiovasc Interv. 2016;87:1036-41.
    PubMed     Text format     Abstract available


  189. MIYASAKA M, Tada N, Kato S, Kami M, et al
    Sheathless guide catheter in transradial percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2016;87:1111-7.
    PubMed     Text format     Abstract available


  190. LEE MH, Park JJ, Yoon CH, Cha MJ, et al
    Impact of smoking status on clinical outcomes after successful chronic total occlusion intervention: Korean national registry of CTO intervention.
    Catheter Cardiovasc Interv. 2016;87:1050-62.
    PubMed     Text format     Abstract available


  191. ORVIN K, Carrie D, Richardt G, Desmet W, et al
    Comparison of sirolimus eluting stent with bioresorbable polymer to everolimus eluting stent with permanent polymer in bifurcation lesions: Results from CENTURY II trial.
    Catheter Cardiovasc Interv. 2016;87:1092-100.
    PubMed     Text format     Abstract available


    April 2016
  192. TURNER ME, Addonizio LJ, Richmond ME, Zuckerman WA, et al
    Percutaneous coronary artery revascularization procedures in pediatric heart transplant recipients: A large single center experience.
    Catheter Cardiovasc Interv. 2016 Apr 16. doi: 10.1002/ccd.26544.
    PubMed     Text format     Abstract available


  193. HIRA RS, Dean LS
    STAR in CTO PCI: When is STAR not a star?
    Catheter Cardiovasc Interv. 2016;87:893-4.
    PubMed     Text format     Abstract available


  194. TURI ZG
    Does a vascular closure device affect the imbalance in complications between radial and femoral access?
    Catheter Cardiovasc Interv. 2016;87:855-6.
    PubMed     Text format     Abstract available


  195. OESTREICH BA, Sommer P, Armstrong EJ
    Coronary artery embolism from infectious endocarditis treated with catheter thrombectomy using a GuideLiner catheter.
    Catheter Cardiovasc Interv. 2016;87:E197-201.
    PubMed     Text format     Abstract available


  196. KERN MJ
    Conversations in cardiology--Is BVS ready for prime time? More about the absorb study.
    Catheter Cardiovasc Interv. 2016;87:902-8.
    PubMed     Text format    


  197. NOMURA T, Higuchi Y, Kato T
    Successful percutaneous coronary intervention for complex bifurcated lesions with combination of "Reverse wire technique" and "Reverse bent wiring with the crusade catheter" novel wire manipulation technique.
    Catheter Cardiovasc Interv. 2016;87:920-5.
    PubMed     Text format     Abstract available


  198. BIJUKLIC K, Schwencke C, Schofer J
    Recanalization of chronic total coronary occlusions--high success rate despite a restrictive use of the retrograde approach.
    Catheter Cardiovasc Interv. 2016;87:E183-91.
    PubMed     Text format     Abstract available


  199. FABRIS E, Caiazzo G, Kilic ID, Serdoz R, et al
    Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres.
    Catheter Cardiovasc Interv. 2016;87:839-46.
    PubMed     Text format     Abstract available


  200. TANAKA A, Ruparelia N, Kawamoto H, Sticchi A, et al
    Clinical outcomes following target lesion revascularization for bioresorbable scaffold failure.
    Catheter Cardiovasc Interv. 2016;87:832-6.
    PubMed     Text format     Abstract available


  201. CARLINO M, Figini F, Ruparelia N, Uretsky BF, et al
    Predictors of restenosis following contemporary subintimal tracking and reentry technique: The importance of final TIMI flow grade.
    Catheter Cardiovasc Interv. 2016;87:884-92.
    PubMed     Text format     Abstract available


  202. SCIAHBASI A, Rigattieri S, Sarandrea A, Cera M, et al
    Radial artery occlusion and hand strength after percutaneous coronary procedures: Results of the HANGAR study.
    Catheter Cardiovasc Interv. 2016;87:868-74.
    PubMed     Text format     Abstract available


  203. OTTERSPOOR LC, Van't Veer M, van Nunen LX, Wijnbergen I, et al
    Safety and feasibility of local myocardial hypothermia.
    Catheter Cardiovasc Interv. 2016;87:877-83.
    PubMed     Text format     Abstract available


  204. SUAREZ DE LEZO J, Martin P, Mazuelos F, Novoa J, et al
    Direct bioresorbable vascular scaffold implantation: Feasibility and midterm results.
    Catheter Cardiovasc Interv. 2016;87:E173-82.
    PubMed     Text format     Abstract available


  205. ALBUQUERQUE FN, Bortnick A, Iqbal J, Ishibashi Y, et al
    Dual antiplatelet therapy, drug-eluting stents and bioresorbable vascular scaffolds: Evolutionary perspectives.
    Catheter Cardiovasc Interv. 2016;87:909-19.
    PubMed     Text format     Abstract available


  206. PAPIREDDY MR, Nandish S, Mishkel GJ
    Recurrent spontaneous coronary artery dissection: First case report in men with three episodes of spontaneous coronary dissection in separate vascular territories.
    Catheter Cardiovasc Interv. 2016;87:E192-6.
    PubMed     Text format     Abstract available


    March 2016
  207. ADUSUMALLI S, Morris M, Pershad A
    Pseudo-Pericardial Tamponade From Right Ventricular Hematoma After Chronic Total Occlusion Percutaneous Coronary Intervention of the Right Coronary Artery: Successfully Managed Percutaneously With Computerized Tomographic Guided Drainage.
    Catheter Cardiovasc Interv. 2016 Mar 29. doi: 10.1002/ccd.26510.
    PubMed     Text format     Abstract available


  208. KLEIN LW, Blankenship JC, Kolansky DM, Dean LS, et al
    SCAI position statement concerning coverage policies for percutaneous coronary interventions based on the appropriate use criteria.
    Catheter Cardiovasc Interv. 2016 Mar 10. doi: 10.1002/ccd.26499.
    PubMed     Text format    


  209. MARKOVIC S, Lutzner M, Rottbauer W, Wohrle J, et al
    Zotarolimus compared with everolimus eluting stents-angiographic and clinical results after recanalization of true coronary chronic total occlusions.
    Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26482.
    PubMed     Text format     Abstract available


  210. IQBAL MB, Nadra IJ, Ding L, Fung A, et al
    Long-term outcomes following drug-eluting stents versus bare metal stents for primary percutaneous coronary intervention: A real-world analysis of 11,181 patients from the british columbia cardiac registry.
    Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26479.
    PubMed     Text format     Abstract available


  211. KARATASAKIS A, Brilakis ES
    Atherectomy for calcified coronary lesions: When and how?
    Catheter Cardiovasc Interv. 2016;87:701-2.
    PubMed     Text format     Abstract available


  212. BUTMAN SM
    Our aspirations still disappoint.
    Catheter Cardiovasc Interv. 2016;87:661-2.
    PubMed     Text format     Abstract available


  213. BLANKENSHIP JC
    When in doubt, aspirate.
    Catheter Cardiovasc Interv. 2016;87:648-9.
    PubMed     Text format     Abstract available


  214. WU Y, Shen L, Ge L, Wang Q, et al
    Six-month outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in treating single de novo lesions in human coronary artery.
    Catheter Cardiovasc Interv. 2016;87 Suppl 1:630-7.
    PubMed     Text format     Abstract available


  215. CHEN X, Zhang D, Yin D, Li J, et al
    Can "true bifurcation lesion" actually be regarded as an independent risk factor of acute side branch occlusion after main vessel stenting?: A retrospective analysis of 1,200 consecutive bifurcation lesions in a single center.
    Catheter Cardiovasc Interv. 2016;87 Suppl 1:554-63.
    PubMed     Text format     Abstract available


  216. XU B, Qian J, Ge J, Wang J, et al
    Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis.
    Catheter Cardiovasc Interv. 2016;87 Suppl 1:624-9.
    PubMed     Text format     Abstract available


  217. TANAKA Y, Saito S
    Successful retrieval of a firmly stuck rotablator burr by using a modified STAR technique.
    Catheter Cardiovasc Interv. 2016;87:749-56.
    PubMed     Text format     Abstract available


  218. HELMY TA, Sanchez CE, Bailey SR
    Coronary and peripheral stenting in aorto-ostial protruding stents: The balloon assisted access to protruding stent technique.
    Catheter Cardiovasc Interv. 2016;87:735-41.
    PubMed     Text format     Abstract available


  219. SECCO GG, Serdoz R, Kilic ID, Caiazzo G, et al
    Indications and immediate and long-term results of a novel pericardium covered stent graft: Consecutive 5 year single center experience.
    Catheter Cardiovasc Interv. 2016;87:712-9.
    PubMed     Text format     Abstract available


  220. DE WAHA S, Allali A, Buttner HJ, Toelg R, et al
    Rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: Two-year clinical outcome of the randomized ROTAXUS trial.
    Catheter Cardiovasc Interv. 2016;87:691-700.
    PubMed     Text format     Abstract available


  221. GIUSTINO G, Baber U, Mastoris I, Vlachojannis GJ, et al
    One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
    Catheter Cardiovasc Interv. 2016;87:703-9.
    PubMed     Text format     Abstract available


  222. AMANN U, Kirchberger I, Heier M, von Scheidt W, et al
    Acute myocardial infarction in the elderly: Treatment strategies and 28-day-case fatality from the MONICA/KORA myocardial infarction registry.
    Catheter Cardiovasc Interv. 2016;87:680-8.
    PubMed     Text format     Abstract available


  223. VO MN, Karmpaliotis D, Brilakis ES
    "Move the cap" technique for ambiguous or impenetrable proximal cap of coronary total occlusion.
    Catheter Cardiovasc Interv. 2016;87:742-8.
    PubMed     Text format     Abstract available


  224. KIM CY, Lee AC, Wiedenbeck TL, Lee MS, et al
    Gender differences in acute and 30-day outcomes after orbital atherectomy treatment of de novo, severely calcified coronary lesions.
    Catheter Cardiovasc Interv. 2016;87:671-7.
    PubMed     Text format     Abstract available


  225. ZIADA KM, Abdel-Latif A, Charnigo R, Moliterno DJ, et al
    Safety of an abbreviated duration of dual antiplatelet therapy (</=6 months) following second-generation drug-eluting stents for coronary artery disease: A systematic review and meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2016;87:722-32.
    PubMed     Text format     Abstract available


  226. KARJALAINEN PP, Mikkelsson J, Paana T, Nammas W, et al
    Clinical outcome of titanium-nitride-oxide-coated cobalt-chromium stents in patients with de novo coronary lesions: 12-month results of the OPTIMAX first-in-man study.
    Catheter Cardiovasc Interv. 2016;87:E122-7.
    PubMed     Text format     Abstract available


  227. WORRALL-CARTER L, McEvedy S, Wilson A, Rahman MA, et al
    Impact of comorbidities and gender on the use of coronary interventions in patients with high-risk non-ST-segment elevation acute coronary syndrome.
    Catheter Cardiovasc Interv. 2016;87:E128-36.
    PubMed     Text format     Abstract available


  228. HISHIKARI K, Kakuta T, Lee T, Murai T, et al
    ST-segment elevation on intracoronary electrocardiogram after percutaneous coronary intervention is associated with worse outcome in patients with non-ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2016;87:E113-21.
    PubMed     Text format     Abstract available


  229. HUANG AL, Murphy JC, Shaw E, Kozor R, et al
    Routine aspiration thrombectomy improves the diagnosis and management of embolic myocardial infarction.
    Catheter Cardiovasc Interv. 2016;87:642-7.
    PubMed     Text format     Abstract available


  230. MORRIS PD, Taylor J, Boutong S, Brett S, et al
    When is rotational angiography superior to conventional single-plane angiography for planning coronary angioplasty?
    Catheter Cardiovasc Interv. 2016;87:E104-12.
    PubMed     Text format     Abstract available


  231. NAKAJIMA Y, Itoh T, Morino Y
    Metal allergy to everolimus-eluting cobalt chromium stents confirmed by positive skin testing as a cause of recurrent multivessel in-stent restenosis.
    Catheter Cardiovasc Interv. 2016;87:E137-42.
    PubMed     Text format     Abstract available


    February 2016
  232. PHILIP F, Stewart S, Southard JA
    Very late stent thrombosis with second generation drug eluting stents compared to bare metal stents: Network meta-analysis of randomized primary percutaneous coronary intervention trials.
    Catheter Cardiovasc Interv. 2016 Feb 24. doi: 10.1002/ccd.26458.
    PubMed     Text format     Abstract available


  233. CHE WQ, Dong H, Jiang XJ, Peng M, et al
    Stenting for left subclavian artery stenosis in patients scheduled for left internal mammary artery-coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2016 Feb 23. doi: 10.1002/ccd.26477.
    PubMed     Text format     Abstract available


  234. RITTGER H, Wohrle J, Brachmann J, Hohenforst-Schmidt W, et al
    Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Catheter Cardiovasc Interv. 2016 Feb 19. doi: 10.1002/ccd.26451.
    PubMed     Text format     Abstract available


  235. ZHANG YJ, Zhu H, Shi SY, Muramatsu T, et al
    Comparison between two-dimensional and three-dimensional quantitative coronary angiography for the prediction of functional severity in true bifurcation lesions: Insights from the randomized DK-CRUSH II, III, and IV trials.
    Catheter Cardiovasc Interv. 2016 Feb 15. doi: 10.1002/ccd.26405.
    PubMed     Text format     Abstract available


  236. ZHANG Q, Hu J, Yang ZK, Ding FH, et al
    Correlates and outcomes related to periprocedural myocardial injury during percutaneous coronary intervention for chronic total occlusion: Results from a prospective, single center PCI registry.
    Catheter Cardiovasc Interv. 2016 Feb 10. doi: 10.1002/ccd.26406.
    PubMed     Text format     Abstract available


  237. KERN MJ, Seto AH
    On the search for an "easy" FFR: Submaximal hyperemia and NTG-induced translesional pressure drop (Pd/Pa-NTG).
    Catheter Cardiovasc Interv. 2016;87:270-2.
    PubMed     Text format    


  238. ALAME A, Brilakis ES
    Best practices for treating coronary ostial lesions.
    Catheter Cardiovasc Interv. 2016;87:241-2.
    PubMed     Text format    


  239. SAFIAN RD
    Restenosis after PCI: Battered but not beaten.
    Catheter Cardiovasc Interv. 2016;87:209-10.
    PubMed     Text format    


  240. GEIR SOLBERG O, Aaberge L, Ragnarsson A, Aas M, et al
    Comparison of simplified and comprehensive methods for assessing the index of microvascular resistance in heart transplant recipients.
    Catheter Cardiovasc Interv. 2016;87:283-90.
    PubMed     Text format     Abstract available


  241. KOLLI KK, van de Hoef TP, Effat MA, Banerjee RK, et al
    Diagnostic cutoff for pressure drop coefficient in relation to fractional flow reserve and coronary flow reserve: A patient-level analysis.
    Catheter Cardiovasc Interv. 2016;87:273-82.
    PubMed     Text format     Abstract available


  242. MARTIN-REYES R, de la Torre Hernandez JM, Franco-Pelaez J, Lopez-Palop R, et al
    The use of the acute Pd/Pa drop after intracoronary nitroglycerin infusion to rule out significant FFR: CANICA (Can intracoronary nitroglycerin predict fractional flow reserve without adenosine?) multicenter study.
    Catheter Cardiovasc Interv. 2016;87:262-9.
    PubMed     Text format     Abstract available


  243. SAW J, Mancini GB, Humphries K, Fung A, et al
    Angiographic appearance of spontaneous coronary artery dissection with intramural hematoma proven on intracoronary imaging.
    Catheter Cardiovasc Interv. 2016;87:E54-61.
    PubMed     Text format     Abstract available


  244. SAKAMOTO N, Hoshino Y, Mizukami H, Sugimoto K, et al
    Intravascular ultrasound predictors of acute side branch occlusion in coronary artery bifurcation lesions just after single stent crossover.
    Catheter Cardiovasc Interv. 2016;87:243-50.
    PubMed     Text format     Abstract available


  245. MCDONAGH JR, Seth M, LaLonde TA, Khandewal AK, et al
    Radial PCI and the obesity paradox: Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    Catheter Cardiovasc Interv. 2016;87:211-9.
    PubMed     Text format     Abstract available


  246. HONDA Y, Muramatsu T, Ito Y, Sakai T, et al
    Impact of ultra-long second-generation drug-eluting stent implantation.
    Catheter Cardiovasc Interv. 2016;87:E44-53.
    PubMed     Text format     Abstract available


  247. BENJO A, Cardoso RN, Collins T, Garcia D, et al
    Vascular brachytherapy versus drug-eluting stents in the treatment of in-stent restenosis: A meta-analysis of long-term outcomes.
    Catheter Cardiovasc Interv. 2016;87:200-8.
    PubMed     Text format     Abstract available


  248. BELARDI J, Manoharan G, Albertal M, Widimsky P, et al
    The influence of age on clinical outcomes in patients treated with the resolute zotarolimus-eluting stent.
    Catheter Cardiovasc Interv. 2016;87:253-61.
    PubMed     Text format     Abstract available


  249. PATEL Y, Depta JP, Patel JS, Masrani SK, et al
    Impact of intravascular ultrasound on the long-term clinical outcomes in the treatment of coronary ostial lesions.
    Catheter Cardiovasc Interv. 2016;87:232-40.
    PubMed     Text format     Abstract available


  250. GREQUE GV, Serrano CV Jr, Strunz CM, Soeiro A, et al
    Preprocedural statin therapy, inflammation, and myocardial injury in low-risk stable coronary artery disease patients submitted to coronary stent implantation.
    Catheter Cardiovasc Interv. 2016;87:222-9.
    PubMed     Text format     Abstract available


  251. KHAN R, Al-Hawwas M, Hatem R, Azzalini L, et al
    Prognostic impact of the residual SYNTAX score on in-hospital outcomes in patients undergoing primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016 Feb 1. doi: 10.1002/ccd.26413.
    PubMed     Text format     Abstract available


    January 2016
  252. DONG H, Jiang X, Peng M, Zou Y, et al
    The interval between carotid artery stenting and open heart surgery is related to perioperative complications.
    Catheter Cardiovasc Interv. 2016 Jan 26. doi: 10.1002/ccd.26408.
    PubMed     Text format     Abstract available


  253. SHAH B, Berger JS, Allen N, Guo Y, et al
    The assessment of thrombotic markers utilizing ionic versus non-ionic contrast during coronary angiography and intervention trial.
    Catheter Cardiovasc Interv. 2016 Jan 16. doi: 10.1002/ccd.26353.
    PubMed     Text format     Abstract available


  254. LEE MS, Yang T, Lasala J, Cox D, et al
    Impact of coronary artery calcification in percutaneous coronary intervention with paclitaxel-eluting stents: Two-year clinical outcomes of paclitaxel-eluting stents in patients from the ARRIVE program.
    Catheter Cardiovasc Interv. 2016 Jan 12. doi: 10.1002/ccd.26395.
    PubMed     Text format     Abstract available


  255. PINTON FA, Lemos PA
    Inflation time in stent deployment: How long is enough?
    Catheter Cardiovasc Interv. 2016;87:73-4.
    PubMed     Text format     Abstract available


  256. HILLEGASS WB
    Insulin-treated diabetes mellitus: An important, actionable risk marker after coronary stenting.
    Catheter Cardiovasc Interv. 2016;87:63-4.
    PubMed     Text format     Abstract available


  257. PATEL PM, Kern MJ
    PCI in failing saphenous vein grafts: DES trumps BMS for the older patient.
    Catheter Cardiovasc Interv. 2016;87:50-1.
    PubMed     Text format     Abstract available


  258. KOLTE D, Dawn Abbott J
    Saphenous vein graft lesions: Are second-generation drug-eluting stents better?
    Catheter Cardiovasc Interv. 2016;87:41-2.
    PubMed     Text format     Abstract available


  259. BANG VV, Levy MS
    In multivessel coronary artery disease, a "state-of-the-art" randomized clinical trial of revascularization is needed.
    Catheter Cardiovasc Interv. 2016;87:13-4.
    PubMed     Text format     Abstract available


  260. MATSUO Y, Kubo T, Aoki H, Satogami K, et al
    Optimal threshold of postintervention minimum stent area to predict in-stent restenosis in small coronary arteries: An optical coherence tomography analysis.
    Catheter Cardiovasc Interv. 2016;87:E9-E14.
    PubMed     Text format     Abstract available


  261. BRENNAN JM, Sketch MH Jr, Dai D, Trilesskaya M, et al
    Safety and clinical effectiveness of drug-eluting stents for saphenous vein graft intervention in older individuals: Results from the medicare-linked National Cardiovascular Data Registry((R)) CathPCI Registry((R)) (2005-2009).
    Catheter Cardiovasc Interv. 2016;87:43-9.
    PubMed     Text format     Abstract available


  262. VALLURUPALLI S, Bahia A, Ruiz-Rodriguez E, Ahmed Z, et al
    Optimization of stent implantation using a high pressure inflation protocol.
    Catheter Cardiovasc Interv. 2016;87:65-72.
    PubMed     Text format     Abstract available


  263. MUNOZ-MENDOZA J, Ghatak A, Pinto Miranda V, Bahadu S, et al
    Time-course of vascular dysfunction of brachial artery after transradial access for coronary angiography.
    Catheter Cardiovasc Interv. 2016;87:101-6.
    PubMed     Text format     Abstract available


  264. URETSKY BF, Mathew J, Ahmed Z, Hakeem A, et al
    Percutaneous management of patients with acute coronary syndromes from unprotected left main disease: A comprehensive review and presentation of a treatment algorithm.
    Catheter Cardiovasc Interv. 2016;87:90-100.
    PubMed     Text format     Abstract available


  265. CARRABBA N, Parodi G, Maehara A, Pradella S, et al
    Rheolityc thrombectomy in acute myocardial infarction: Effect on microvascular obstruction, infarct size, and left ventricular remodeling.
    Catheter Cardiovasc Interv. 2016;87:E1-8.
    PubMed     Text format     Abstract available


  266. POKALA NR, Menon RV, Patel SM, Christopoulos G, et al
    Long-term outcomes with first- vs. second-generation drug-eluting stents in saphenous vein graft lesions.
    Catheter Cardiovasc Interv. 2016;87:34-40.
    PubMed     Text format     Abstract available


  267. PANAICH SS, Badheka AO, Arora S, Patel NJ, et al
    Variability in utilization of drug eluting stents in United States: Insights from nationwide inpatient sample.
    Catheter Cardiovasc Interv. 2016;87:23-33.
    PubMed     Text format     Abstract available


  268. BARTORELLI AL, Egidy Assenza G, Abizaid A, Banning A, et al
    One-year clinical outcomes after sirolimus-eluting coronary stent implantation in diabetics enrolled in the worldwide e-SELECT registry.
    Catheter Cardiovasc Interv. 2016;87:52-62.
    PubMed     Text format     Abstract available


  269. KATOH H, Nozue T, Michishita I
    A case of giant saphenous vein graft aneurysm successfully treated with catheter intervention.
    Catheter Cardiovasc Interv. 2016;87:83-9.
    PubMed     Text format     Abstract available


  270. BURZOTTA F, Summaria F, Latib A, De Vita M, et al
    Prospective multicentre clinical performance evaluation of second and third generation zotarolimus-eluting stents to treat patients with bifurcated coronary lesions.
    Catheter Cardiovasc Interv. 2016;87:15-22.
    PubMed     Text format     Abstract available


  271. ZIMARINO M, Ricci F, Romanello M, Di Nicola M, et al
    Complete myocardial revascularization confers a larger clinical benefit when performed with state-of-the-art techniques in high-risk patients with multivessel coronary artery disease: A meta-analysis of randomized and observational studies.
    Catheter Cardiovasc Interv. 2016;87:3-12.
    PubMed     Text format     Abstract available


  272. LU H, Ge L, Ge J
    Coronary aneurysm and stent fracture following stenting of a myocardial bridge.
    Catheter Cardiovasc Interv. 2016;87:E15-8.
    PubMed     Text format     Abstract available


    December 2015
  273. HABARA M, Tsuchikane E, Muramatsu T, Kashima Y, et al
    Comparison of percutaneous coronary intervention for chronic total occlusion outcome according to operator experience from the Japanese retrograde summit registry.
    Catheter Cardiovasc Interv. 2015 Dec 31. doi: 10.1002/ccd.26354.
    PubMed     Text format     Abstract available


  274. HOPPMANN P, Kufner S, Cassese S, Wiebe J, et al
    Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice: Results of the ISAR-ABSORB registry.
    Catheter Cardiovasc Interv. 2015 Dec 28. doi: 10.1002/ccd.26346.
    PubMed     Text format     Abstract available


  275. CHEN SH, Ho KK, Gannon SA, Thyagarajan B, et al
    Utility of a real-time appropriate use criteria decision support application for percutaneous coronary interventions in non-acute coronary syndrome.
    Catheter Cardiovasc Interv. 2015 Dec 23. doi: 10.1002/ccd.26350.
    PubMed     Text format     Abstract available


  276. DERY JP, Mahaffey KW, Tricoci P, White HD, et al
    Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar.
    Catheter Cardiovasc Interv. 2015 Dec 23. doi: 10.1002/ccd.26335.
    PubMed     Text format     Abstract available


    November 2015
  277. NASCIMBENE A, Loyalka P, Gregoric ID, Kar B, et al
    Percutaneous coronary intervention with the TandemHeart percutaneous left ventricular assist device support: Six years of experience and outcomes.
    Catheter Cardiovasc Interv. 2015 Nov 21. doi: 10.1002/ccd.26147.
    PubMed     Text format     Abstract available


  278. LARMORE C, Effron MB, Molife C, DeKoven M, et al
    "Real-World" comparison of prasugrel with ticagrelor in patients with acute coronary syndrome treated with percutaneous coronary intervention in the United States.
    Catheter Cardiovasc Interv. 2015 Nov 18. doi: 10.1002/ccd.26279.
    PubMed     Text format     Abstract available


  279. SAFIAN RD
    Will invasive coronary imaging identify vulnerable plaque and predict future cardiac events?
    Catheter Cardiovasc Interv. 2015;86:1022-3.
    PubMed     Text format     Abstract available


  280. YOSHIMACHI F, Torii S, Naito T
    A novel percutaneous coronary intervention technique for chronic total occlusion: Contralateral angiography with a single guiding catheter.
    Catheter Cardiovasc Interv. 2015 Nov 3. doi: 10.1002/ccd.26268.
    PubMed     Text format     Abstract available


  281. SANCHEZ CE, Dota A, Badhwar V, Kliner D, et al
    Revascularization heart team recommendations as an adjunct to appropriate use criteria for coronary revascularization in patients with complex coronary artery disease.
    Catheter Cardiovasc Interv. 2015 Nov 3. doi: 10.1002/ccd.26276.
    PubMed     Text format     Abstract available


  282. ELGENDY IY, Wen X, Mahmoud A, Bavry AA, et al
    Complete versus culprit-only revascularization for patients with multi-vessel disease undergoing primary percutaneous coronary intervention: An updated meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2015 Nov 3. doi: 10.1002/ccd.26322.
    PubMed     Text format     Abstract available


    September 2015
  283. SINGH RAO R, Shapiro RL, Lasala JM
    No reflow leading to catastrophic hemodynamic collapse in a patient with severe aortic stenosis and its management.
    Catheter Cardiovasc Interv. 2015 Sep 10. doi: 10.1002/ccd.26233.
    PubMed     Text format     Abstract available


  284. KHEIWA A, Turner D, Schreiber T
    Left main coronary artery embolization in an 11-year-old girl due to inflammatory myofibroblastic tumor of the mitral valve.
    Catheter Cardiovasc Interv. 2015 Sep 2. doi: 10.1002/ccd.26149.
    PubMed     Text format     Abstract available


  285. HILLEGASS WB
    Diabetes is not sufficient justification for IIb/IIIa use in percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2015;86:376-7.
    PubMed     Text format     Abstract available


    June 2015
  286. ALONZO A, Rigattieri S, Giovannelli F, Di Russo C, et al
    Transfemoral approach with systematic use of FemoSeal closure device compared to transradial approach in primary angioplasty.
    Catheter Cardiovasc Interv. 2015 Jun 23. doi: 10.1002/ccd.26076.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: